Close

gag p17

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Matrix protein p17: Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus. Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA

Associated Disease
  • HIV-1 infection
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-C063Z Human anti-gag p17 T cell receptor (1803), pCDTCR1 HIV-1 1803 Human SLYNTVATL HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-C064Z Human anti-gag p17 T cell receptor (G10), pCDTCR1 HIV G10 Human SLYNTVATL HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C065Z Human anti-gag p17 T cell receptor (T5-004), pCDTCR1 HIV T5-004 Human SLYNTVATL HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C066Z Human anti-gag p17 (SLFNTVATL) T cell receptor (G10), pCDTCR1 HIV G10 Human SLFNTVATL HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C067Z Human anti-gag p17 (SLFNTVATL) T cell receptor (T5-004), pCDTCR1 HIV T5-004 Human SLFNTVATL HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C068Z Human anti-gag p17 T cell receptor (1.9), pCDTCR1 HIV 1.9 Human SLYNTVATL HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-C069Z Human anti-gag p17 T cell receptor (52H8), pCDTCR1 HIV 52H8 Human RLRPGGKKK HLA-A3 Lentiviral   Add to Cart   Datasheet
TCR-C070Z Human anti-gag p17 T cell receptor (C-4), pCDTCR1 HIV-1 C-4 Human SLYNTVATL HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C071Z Human anti-gag p17 T cell receptor, pCDTCR1 HIV-1 Human SLYNTVATL HLA-A*0201 Lentiviral   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.